{"url":"https://lda.senate.gov/api/v1/filings/9f769f6c-bca6-441e-9fc9-e609d19c2dfa/","filing_uuid":"9f769f6c-bca6-441e-9fc9-e609d19c2dfa","filing_type":"Q3","filing_type_display":"3rd Quarter - Report","filing_year":2020,"filing_period":"third_quarter","filing_period_display":"3rd Quarter (July 1 - Sep 30)","filing_document_url":"https://lda.senate.gov/filings/public/filing/9f769f6c-bca6-441e-9fc9-e609d19c2dfa/print/","filing_document_content_type":"text/html","income":"80000.00","expenses":null,"expenses_method":null,"expenses_method_display":null,"posted_by_name":"Jonathon Jones, Partner","dt_posted":"2020-10-20T15:02:00.893000-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"1300 Connecticut Ave., NW","registrant_address_2":"Suite 600","registrant_different_address":false,"registrant_city":"Washington","registrant_state":"DC","registrant_zip":"20036","registrant":{"id":312213,"url":"https://lda.senate.gov/api/v1/registrants/312213/","house_registrant_id":38712,"name":"TIBER CREEK","description":"Government relations.","address_1":"1300 Connecticut Ave., NW","address_2":"Suite 600","address_3":null,"address_4":null,"city":"Washington","state":"DC","state_display":"District of Columbia","zip":"20036","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"ELIZABETH DOWN","contact_telephone":"+1 202-775-8116","dt_updated":"2022-04-06T16:08:26.968761-04:00"},"client":{"id":183944,"url":"https://lda.senate.gov/api/v1/clients/183944/","client_id":36,"name":"CIGNA CORPORATION","general_description":"Employee benefits company.","client_government_entity":false,"client_self_select":false,"state":"DC","state_display":"District of Columbia","country":"US","country_display":"United States of America","ppb_state":"CT","ppb_state_display":"Connecticut","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2013-02-26"},"lobbying_activities":[{"general_issue_code":"MMM","general_issue_code_display":"Medicare/Medicaid","description":"Proposals that impact Medicare Part D. Ongoing implementation of payment and regulatory issues for the Medicare Advantage program. Issues related to H.R. 7839 Continuing Access to In Home IVIG Act","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":58151,"prefix":null,"prefix_display":null,"first_name":"ANDREW","nickname":null,"middle_name":null,"last_name":"MCKECHNIE","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":73313,"prefix":null,"prefix_display":null,"first_name":"ASHLI","nickname":null,"middle_name":null,"last_name":"PALMER","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":136,"name":"Centers For Medicare and Medicaid Services (CMS)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"},{"id":12,"name":"White House Office"}]},{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"Issues relating to P.L. 111-148, the Patient Protection and Affordable Care Act and P.L. 111-152, the Health Care and Education Reconciliation Act. Issues related to prescription drug pricing. Federal COVID response.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":58151,"prefix":null,"prefix_display":null,"first_name":"ANDREW","nickname":null,"middle_name":null,"last_name":"MCKECHNIE","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":73313,"prefix":null,"prefix_display":null,"first_name":"ASHLI","nickname":null,"middle_name":null,"last_name":"PALMER","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":136,"name":"Centers For Medicare and Medicaid Services (CMS)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"},{"id":12,"name":"White House Office"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]}